Citigroup Inc Madrigal Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 28,621 shares of MDGL stock, worth $8.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,621

Previous 16,062 78.19%

Holding current value

$8.83 Million

Previous $4.5 Million 34.99%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$212.22 - $292.96 $2.67 Million - $3.68 Million	12,559 Added 78.19%	28,621 $6.07 Million
Q2 2024 Aug 12, 2024	SELL	$193.33 - $291.99 $3.23 Million - $4.88 Million	-16,728 Reduced 51.02%	16,062 $4.5 Million
Q1 2024 May 10, 2024	BUY	$171.37 - $283.23 $1.97 Million - $3.25 Million	11,467 Added 53.78%	32,790 $8.76 Million
Q4 2023 Feb 09, 2024	SELL	$120.4 - $237.13 $115,704 - $227,881	-961 Reduced 4.31%	21,323 $4.93 Million
Q3 2023 Nov 09, 2023	BUY	$146.04 - $225.78 $965,470 - $1.49 Million	6,611 Added 42.18%	22,284 $3.25 Million
Q2 2023 Aug 10, 2023	SELL	$203.88 - $312.0 $1.58 Million - $2.41 Million	-7,740 Reduced 33.06%	15,673 $3.62 Million
Q1 2023 May 11, 2023	SELL	$231.06 - $307.08 $5.35 Million - $7.1 Million	-23,136 Reduced 49.7%	23,413 $5.67 Million
Q4 2022 Feb 09, 2023	SELL	$58.39 - $296.54 $799,826 - $4.06 Million	-13,698 Reduced 22.74%	46,549 $13.5 Million
Q3 2022 Nov 10, 2022	BUY	$60.57 - $79.51 $1.69 Million - $2.22 Million	27,931 Added 86.43%	60,247 $3.92 Million
Q2 2022 Aug 10, 2022	BUY	$58.04 - $100.2 $1.41 Million - $2.43 Million	24,268 Added 301.54%	32,316 $2.31 Million
Q1 2022 May 12, 2022	SELL	$55.89 - $101.89 $1.27 Million - $2.31 Million	-22,652 Reduced 73.79%	8,048 $790,000
Q4 2021 Feb 10, 2022	SELL	$72.34 - $95.09 $513,107 - $674,473	-7,093 Reduced 18.77%	30,700 $2.6 Million
Q3 2021 Nov 10, 2021	BUY	$78.35 - $105.02 $2.96 Million - $3.97 Million	37,793 New	37,793 $3.02 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account